West Tower Group’s Idexx Laboratories IDXX Stock Holding History

West Tower Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-36	Closed	-$20K	–	289
2023 Q4	$20K	Buy	+36	New	+$16.9K	0.04%	287
2023 Q3	–	Sell	-24	Closed	-$12.1K	–	701
2023 Q2	$12.1K	Buy	+24	New	+$11.5K	0.01%	404

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

West Tower Group's IDXX Position: Q1 2024 in Review

West Tower Group sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 36 shares — an estimated $20K sold.

West Tower Group first reported a position in IDXX in Q2 2023 and held it in 2 quarters. The position peaked at $20K in Q4 2023. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

West Tower Group reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
West Tower Group sold 36 Idexx Laboratories shares in Q1 2024, an estimated $20K.
West Tower Group first reported a position in Idexx Laboratories in Q2 2023 and held it in 2 quarters.
West Tower Group's Idexx Laboratories position peaked at $20K in Q4 2023.
1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on West Tower Group's 13F filing for Q1 2024, filed 14 May 2024.